A post arguing "ADHD is real" and listing brain imaging, genetics and neurochemistry as evidence is circulating, aimed at pushing back on the idea that ADHD is just poor discipline or a lack of willpower. The general claim holds up well against the actual research, though a few of the details deserve more precision than a summary graphic can give. Here is what each pillar of evidence actually shows.
Physical brain differences
The largest study of its kind, led by the ENIGMA consortium and published in The Lancet Psychiatry, compared brain scans from 1,713 people with ADHD and 1,529 without, across 23 research sites worldwide. It found smaller volumes in several subcortical brain structures in people with ADHD, including the amygdala, caudate, hippocampus, putamen and nucleus accumbens, along with a smaller total brain volume. These are structures involved in emotion regulation, motivation and movement control, not just "attention" in the abstract.
A real, specific finding on brain maturation
The claim about delayed development traces back to a well-known 2007 study in the Proceedings of the National Academy of Sciences, which tracked brain scans of 223 children with ADHD and 223 without over several years. Cortical thickness in children with ADHD peaked around age 10.5, roughly three years later than the age 7.5 peak seen in the comparison group, with the delay most pronounced in the prefrontal regions involved in attention and impulse control. Importantly, the trajectories were parallel, not different in shape, which is why researchers describe this as a maturational lag rather than abnormal development.
Neurochemistry: more complicated than "low dopamine"
The dopamine story is real but messier than a simple deficiency. A meta-analysis of nine brain-imaging studies found that dopamine transporter levels in ADHD were not consistently lower across all studies, and the picture depended heavily on whether participants had previously taken ADHD medication. Studies of people who had never taken stimulant medication tended to show lower dopamine transporter availability, while prior stimulant treatment was associated with higher levels, likely reflecting how the medication itself changes the system it is treating. The honest summary: dopamine signaling does appear to work differently in ADHD, but "low dopamine" is a simplification of a more complicated, treatment-sensitive picture.
Genetic predisposition
This is the strongest and most consistent pillar. A 2019 review pooling data from 37 twin studies estimated ADHD's heritability at around 74 percent, meaning genetic factors account for roughly three-quarters of the variation in ADHD traits across the population studied. That is comparable to the heritability of height, and higher than that of many other psychiatric conditions. Heritability held up similarly across sexes and across inattentive and hyperactive-impulsive symptom types.
What this all adds up to
Across structural imaging, developmental trajectory, neurochemistry and genetics, the evidence consistently points to ADHD as a real, biologically grounded difference in how the brain develops and functions, not a character flaw or a parenting outcome. The precise mechanisms are still being worked out, and some claims (like "low dopamine") are more nuanced in the primary literature than in a shareable graphic, but the core message holds: this is a documented, biological difference in how certain brains are wired.
If this resonates with your own experience, our free ADHD screening can help you put words to what you are noticing before a conversation with a clinician.
Sources: Hoogman et al., "Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults," The Lancet Psychiatry (2017); Shaw et al., "Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation," PNAS (2007); Fusar-Poli et al., "Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis," American Journal of Psychiatry (2012); Faraone and Larsson, "Genetics of attention deficit hyperactivity disorder," Molecular Psychiatry (2019). Educational summary - not a diagnosis or medical advice.